Where PBPK Meets the Chip: Notes from the MPS World Summit Through a PBPK Modeler’s Lens
Last week, the MPS World Summit took place at [...]
ESQlabs at the International workshop towards harmonisation of QIVIVE in risk assessment
Last week, our colleagues Dr. Stella Fragki and Dr. [...]
PBPK for Drug-Drug Interactions: Why It Matters
If you are in drug development, there is one [...]
ESQlabs Brings Next-Generation Risk Assessment to the United States
ESQlabs, a European leader in physiologically based kinetic (PBPK) modeling, and [...]
Our latest Face to Face was once again, a meeting to remeber
This time, we gathered in Athens: a city rich [...]
